British Biotech Spin-Offs Get €40M Funding to Treat Narcolepsy
Orexia and Inexia, two new virtual companies spun out of Sosei Heptares, will develop drugs…
06/02/2019 - 2 minutes
Heptares Therapeutics
British Biotech Founder Receives the Nobel Prize in Chemistry 2017
Richard Henderson, awarded the Nobel Prize in Chemistry 2017, founded Heptares Therapeutics to apply his Nobel-winning technology…
05/10/2017 - 2 minutes
Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal
Allergan's partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat…
01/09/2017 - 2 minutes
Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares
Heptares is expanding into a range of indications with its GPCR platform. I caught up…
17/07/2017 - 6 minutes
A Painful Case: How Biotech is trying to Break Through in Analgesia
Just 2% of experimental pain treatments clear Phase II. Why is this challenge so great,…
06/06/2017 - 7 minutes
Heptares receives €4.5M Milestone for New Migraine Drug Candidate
The UK biotech attacking notoriously evasive GPCRs has discovered a small molecule that could be…
18/05/2017 - 1 minute
Heptares Finds New GPCR Target to Treat Pain, Cancer and Inflammation
Heptares Therapeutics has published the detailed structure and mechanism of action of a difficult-to-target GPCR…
27/04/2017 - 2 minutes
Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor
Heptares Therapeutics has achieved a new milestone in its immuno-oncology collaboration with AstraZeneca triggering an…
05/04/2017 - 3 minutes
What are the Best Countries to Recruit Biotech Talents in 2017?
Before the “who to recruit” phase, an important question is “where?” We ran through the…
15/03/2017 - 10 minutes
New British Biotech-Academia Alliance takes on Cardiovascular Disease
Heptares Therapeutics and the University of Cambridge have partnered to investigate a novel target for…
31/01/2017 - 2 minutes
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…
26/12/2016 - 5 minutes
Drugging the Undruggable: New Acquisition to Boost GPCR Drugs
Heptares Therapeutics has acquired G7 Therapeutics to take control over its GPCR technology, boost its…
30/11/2016 - 2 minutes
